Early day motion tabled by primary sponsor Lynne Jones (Labour), on Tuesday, 3 December 2002, in the House of Commons. It is signed by 156 members in total.

---

BEST PRACTICE FOR PEOPLE WITH SCHIZOPHRENIA

That this House welcomes the National Institute for Clinical Excellence's Technology Appraisal Guidance No. 43 on the use of newer, atypical antipsychotic drugs for the treatment of schizophrenia, issued in June 2002; believes that the guidance is a real step forward in delivering better care for those with schizophrenia; recognises the importance of ensuring that patients have an informed choice about their treatment options; recalls the NHS' statutory obligation to ensure that all NICE recommendations are implemented within three months of issue; notes the concerns raised at the Rethink severe mental illness conference, Only the Best in December 2002 over the slowness of implementation; and urges NHS trusts, health authorities and primary care trusts to ensure that sufficient funding is made available to implement the NICE guidance quickly and effectively to improve the lives of those with schizophrenia.

---

Secondary information

Type

Early day motion

Reference

263 

Session

2002-03

Subjects

Medical treatments Prescription drugs Schizophrenia

Link

View this Early day motion on www.parliament.uk